Best GLP-1 Online Programs: Top Telehealth Providers Compared (2026)

Affiliate Disclosure: Some providers on this page are affiliate partners. This does not affect our rankings or analysis. We have declined to feature providers that did not meet our standards, including some that offered partnerships.

The Short Answer — Which GLP-1 Online Program Is Best?

No single program is best for everyone. The right pick depends on whether you want FDA-approved brand-name medication or are open to compounded options, whether you are paying cash or using insurance, and whether you prefer injections or would rather avoid needles entirely.

Here is how we sort it:

Best overall for most self-pay users — MEDVi.

MEDVi still stands out for self-pay users who are open to compounded GLP-1s because its core compounded program is still marketed from $179 for month one, with tablets starting at $249 and 24/7 support included. But MEDVi is no longer best described as a compounded-only provider. Its current product pages also show Wegovy® pill, Wegovy® injection, and Zepbound® injection, which are presented separately as $99 membership + medication and marked subject to availability.

The better way to describe MEDVi now is hybrid: a strong compounded entry point, plus newer branded paths. Compounded products are still not FDA-approved as finished drugs, and that tradeoff still matters. But if you want one platform that currently surfaces both lower-cost compounded options and some branded routes, MEDVi remains the strongest default starting point for most self-pay users.

MEDVi

#1 Pick — March 2026

GLP-1 Weight Loss Program

11,498verified reviews

on Trustpilot

“Lost 16 lbs in 10 weeks — no side effects. Down two sizes. I wish I’d started sooner.”

— Verified MEDVi patient on ConsumerAffairs ★★★★★

Get a prescription from your couch — no appointments, no waiting rooms

Compounded plans from $179; branded options also currently listed

Doctor-led plans, unlimited appointments, and 24/7 support

Chosen by more of our readers than any other program

Check My Eligibility →Check current eligibility, pricing, and availability

GMP Certified

3rd-Party Tested

US-Licensed Clinicians

Best for flat pricing at every dose — Eden.

Your monthly cost does not increase as your dose goes up, which is rare. If you want to know exactly what you will pay six months from now, Eden is the pick.

Best dedicated brand-name-first platform — Hims / Hers.

Among the largest consumer telehealth platforms in the U.S. Hims announced a March 2026 collaboration with Novo Nordisk to add branded semaglutide medicines, including Wegovy, to the platform. If you want a clean, mainstream, brand-name-first route, start here.

Best for needle-free options — Willow.

Willow emphasizes oral semaglutide tablets and a no-needle approach. If weekly injections are a dealbreaker, Willow is worth a look.

Best budget alternatives — SkinnyRx and TrimRx.

Lower entry pricing for cost-conscious users who want compounded GLP-1 access without extra membership layers.

Not sure which path fits? Keep reading — the comparison table, full reviews, and our free 60-second matching quiz will make it clear.

Which GLP-1 Program Fits Your Situation?

Before you compare providers, answer one question first: what route do you want?

There are three ways to access GLP-1 medication online in 2026, and they come with very different price tags, regulatory profiles, and tradeoffs.

Here is a quick-match framework. Find your row:

GLP-1 Online Programs Compared: Pricing, Support, and Trust Signals

This table reflects data verified as of April 2026. We check pricing, pharmacy status, review scores, and program details monthly. If something has changed, let us know.

How to use this table: Find the column that matters most to you — cost, medication type, or support level — and compare across rows. Every provider includes a link to verify current details on their site.

Each provider on this list states that it uses U.S.-licensed clinicians. Pharmacy transparency varies — we note publicly disclosed sourcing details where available. We excluded programs with deceptive pricing, no meaningful clinical oversight, or marketing that misrepresented medication type.

What Changed in the GLP-1 Market in 2026 — and Why It Matters

Full Reviews of the Best GLP-1 Online Programs

We use the same template for every provider so you can compare apples to apples.

MEDVi Review: Best Overall GLP-1 Program for Self-Pay Users

Bottom line: MEDVi still earns the top overall self-pay spot, but the rationale is more nuanced now. Its core offer is still a low-entry-price compounded GLP-1 program with strong support and very large review volume. At the same time, MEDVi’s current product navigation also shows branded Wegovy pill, branded Wegovy injection, and Zepbound injection. The better description now is hybrid: a strong compounded starting point, with branded paths also appearing on the platform.

Quick facts:

• Monthly cost: Compounded path starts at $179 month one, with month-to-month compounded pricing at $299; branded paths are currently shown as $99 membership + medication cost
• Medications: Compounded semaglutide and tirzepatide injections + compounded tablets; current product navigation also shows Wegovy pill, Wegovy injection, and Zepbound injection
• Support: 24/7 support + unlimited appointments
• Clinician network: OpenLoop Health (licensed U.S. physicians)
• Pharmacy: Licensed U.S. compounding pharmacies (specific pharmacy partners referenced on MEDVi’s site)
• Contract: Compounded program appears month-to-month; branded paths should be verified at checkout
• Cancellation: Cancel at least 72 hours before next billing date
• Trustpilot: 4.4/5 from 11,498 reviews as of April 10, 2026

What we like:

The compounded all-in pricing model is still the standout. Your compounded plan covers the clinician consultation, medication, shipping, and support access with no separate membership fee or hidden consult charges. But do not assume that MEDVi uses one universal pricing structure across every medication path, because its current branded routes are presented separately as membership plus medication. In a category where “starting at $149” often means “plus a $79 visit fee and $12 shipping and by the way your price doubles at 1mg,” the compounded all-in clarity still matters.

The review volume is also meaningful. 11,498 Trustpilot reviews with a 4.4 rating gives you more signal than a provider with 50 reviews and a perfect score. You can read real experiences — good and bad — from thousands of actual patients.

MEDVi also offers both injection and oral tablet formats, which gives flexibility if you want to start with one and explore the other.

What real users are saying:

“MEDVi Doctors & Staff have been very professional and prompt with any questions I have and their support & care. I feel in great hands! I’m 13lbs away from goal... Thank you!” — Verified Trustpilot review, February 2026

“The doctor took his time in talking with me. He explained the new med, tirzepatide. He said it was stronger than semaglutide and that is what I’m looking for.” — Verified Trustpilot review, March 2026

“My Clinician was kind, informative, gave a clear understanding of expectations, what was needed and future follow ups and dosage changes.” — Verified Trustpilot review

What to know before choosing:

MEDVi’s core offering is compounded GLP-1 medications. These are not FDA-approved as finished products. The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed, and the agency has stated that compounded drugs are not the same as FDA-approved generics. In February 2026, MEDVi received an FDA warning letter related to marketing claims about its compounded products — part of a broader industry-wide enforcement wave that reached 30 companies by March 2026.

We are not going to pretend that does not matter. It does. But here is the context: the FDA’s concern was specifically about marketing language that implied compounded products are equivalent to FDA-approved drugs. The agency was not shutting down compounding or declaring these programs illegal. Compounded medications prepared by licensed pharmacies under valid prescriptions remain a legal and widely used access path. The real question is whether you are comfortable with the compounding tradeoff — lower cost, but not the same regulatory review as brand-name products. If that regulatory distinction matters a lot to you, Hims or Hers still offer the cleaner brand-name-first experience. But MEDVi now also appears to surface branded Wegovy and Zepbound paths on its current product page. The more important caution now is to verify whether your plan is compounded or brand-name and confirm the full price before checkout, because MEDVi’s public pages are not perfectly unified.

We also want to flag that some Trustpilot reviewers have mentioned billing friction around cancellations and occasional customer service delays. These complaints exist alongside the overwhelmingly positive reviews. Read the recent reviews yourself — that is exactly what Trustpilot is for.

Best for: Self-pay users who want a strong compounded starting point, very large review volume, and the option to explore branded paths inside the same ecosystem.

Not best for: People who want a clean brand-name-only experience with fully transparent branded pricing upfront.

MEDVi

#1 Pick — March 2026

GLP-1 Weight Loss Program

11,498verified reviews

on Trustpilot

“Lost 16 lbs in 10 weeks — no side effects. Down two sizes. I wish I’d started sooner.”

— Verified MEDVi patient on ConsumerAffairs ★★★★★

Get a prescription from your couch — no appointments, no waiting rooms

Compounded plans from $179; branded options also currently listed

Doctor-led plans, unlimited appointments, and 24/7 support

Chosen by more of our readers than any other program

Check My Eligibility →Check current eligibility, pricing, and availability

GMP Certified

3rd-Party Tested

US-Licensed Clinicians

Honest Tradeoffs — Who Should Skip Each Option?

This section exists because most “best of” pages skip it. Telling you who each program is not for builds more trust than pretending everyone is a fit for everything.

Brand-Name vs. Compounded GLP-1s: The Decision You Need to Make First

Brand-name (FDA-approved) means Wegovy and Zepbound for weight loss, manufactured by Novo Nordisk and Eli Lilly respectively, fully reviewed by the FDA for safety and effectiveness. (Ozempic and Mounjaro are FDA-approved for type 2 diabetes and may be prescribed off-label for weight loss.) This is the gold standard for regulatory certainty. Pricing varies significantly by product and dose: oral Wegovy starts at $149/month for lower doses under Novo Nordisk’s self-pay program, with higher doses at $199–$299/month. Injectable brand-name pricing can be substantially higher. In early 2026, Novo Nordisk launched an oral version of Wegovy (semaglutide tablets) that is FDA-approved for weight loss in adults — the first approved GLP-1 weight-loss pill.

Compounded means a licensed U.S. compounding pharmacy prepares semaglutide or tirzepatide under a clinician’s prescription. These products are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality before they reach you. They are also not the same as generic drugs. The FDA has been clear on this point, and in 2025 and 2026 has significantly escalated enforcement against companies whose marketing blurred that line. Monthly cost: typically $149 to $399.

What to avoid entirely: Products sold without a prescription, anything labeled “research use only,” GLP-1 products from overseas or unregulated sellers, and any provider that guarantees approval before a clinician evaluates you. The FDA maintains active consumer warnings about these.

The honest middle ground: Most providers on this list offer compounded medications. That is the reality of the affordable GLP-1 market in 2026. We do not pretend compounded products have the same regulatory review as brand-name products — they do not. But for self-pay users without insurance coverage, a compounded program with transparent pharmacy sourcing, licensed clinicians, and clear pricing is, for many people, the most practical path to treatment.

How to decide between brand-name and compounded for your situation: If you have insurance that covers GLP-1 medications, start with the brand-name route — it costs you less out of pocket and gives you FDA-reviewed products. If you are paying cash and $900+ per month is not realistic, a compounded program through a reputable provider is a legitimate alternative that a large and growing number of people are using. If you are somewhere in between — maybe you have insurance but are not sure what it covers — check with Hims or Hers first if you want to explore a brand-name path that may work with your insurance. The worst option is doing nothing because the choices feel overwhelming. Pick a lane, verify the provider, and start.

What Do GLP-1 Programs Actually Cost? Hidden Fees to Watch For

The price you see advertised is almost never the price you end up paying.

A rough 90-day cost projection:

Estimates based on published pricing as of April 2026. Verify current pricing directly with each provider.

How Do Online GLP-1 Programs Work?

If you are using a cash-pay telehealth program, you typically do not need a referral from your PCP. If you are using insurance for brand-name medication, prior authorization is often required — Wegovy and Zepbound coverage commonly involves this step.

What about follow-up care? This varies by provider, and it matters more than most people realize. GLP-1 treatment is not a one-and-done prescription. You will need dose adjustments as you titrate up, side-effect management (especially in the first few weeks), and eventually a conversation about maintenance or discontinuation. The depth of follow-up ranges from 24/7 messaging (MEDVi) to asynchronous chat with multi-day response times (budget programs). Ask yourself honestly: if you feel nauseous after your first dose increase, do you want to be able to message someone right away? That answer should factor into your choice.

How long does treatment typically last? The clinical trials that produced the headline weight-loss numbers ran for 68 to 72 weeks. This is not a 30-day fix — it is a treatment arc. Your provider should be managing it accordingly, with structured dose titration and periodic check-ins to assess your progress and adjust the plan.

Do You Qualify for a GLP-1 Online Program?

Standard eligibility criteria, based on FDA labeling for Wegovy and Zepbound:

• BMI of 30 or higher (obesity), OR
• BMI of 27 or higher with at least one weight-related health condition — such as high blood pressure, type 2 diabetes, high cholesterol, sleep apnea, or PCOS
• Age 18 or older for the telehealth programs on this page

Who should not use GLP-1 medications (per FDA prescribing information):

• Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Known serious hypersensitivity to semaglutide, tirzepatide, or any product components
• Currently pregnant, breastfeeding, or planning pregnancy — Wegovy labeling advises stopping at least two months before a planned pregnancy
• History of pancreatitis — a precaution requiring clinician evaluation, not automatic disqualification
• Severe gastroparesis or significant GI motility disorders

Billing models vary by provider — some charge an intake fee regardless of approval, while others only charge if you proceed with treatment. Verify the current payment terms on each provider’s site before starting.

For a deeper dive: Complete GLP-1 contraindications guide

How Much Weight Can You Realistically Lose?

Clinical trial data (brand-name medications at full doses with close monitoring):

• Semaglutide 2.4mg (Wegovy injection): ~15% average body weight reduction over 68 weeks. For a 220-pound person, roughly 33 pounds.
• Tirzepatide 15mg (Zepbound): ~22.5% average body weight reduction over 72 weeks. For a 220-pound person, roughly 50 pounds.
• Head-to-head: Tirzepatide outperformed semaglutide directly — 20.2% vs 13.7% average weight loss.

These results come from controlled clinical trials using brand-name medications. Real-world results tend to come in somewhat lower due to adherence variation, dosing differences, and individual biology. The medications are effective — the variables are adherence, dosing, and which support system fits your life.

GLP-1 Side Effects: What to Expect

Common side effects per FDA prescribing information for semaglutide and tirzepatide products:

Most common: Nausea (most frequently reported, especially in the first few weeks and at dose increases), constipation, diarrhea, stomach pain, headache, fatigue. These are typically dose-dependent and improve as your body adjusts.

How to manage: Start at the lowest dose and titrate slowly. Eat smaller meals. Stay well hydrated. Avoid high-fat or greasy foods during titration. Some people find eating protein-rich, smaller meals helps considerably. If nausea is persistent, talk to your clinician about adjusting the titration schedule.

Serious but rare: Severe abdominal pain that does not go away (possible pancreatitis — stop medication and seek care immediately), signs of allergic reaction, gallbladder problems, changes in vision. FDA prescribing information for all GLP-1 products includes a boxed warning about thyroid C-cell tumors observed in animal studies — patients with a personal or family history of MTC or MEN2 should not use these medications.

The bottom line on side effects: They are real, they are manageable for most people, and they are the reason every program on this list includes clinician access. You should not be navigating dose adjustments and side effects alone. If a program does not give you a way to reach a medical provider when something feels off, that is a red flag — and a reason to choose a different program.

Will Insurance Cover Any of This?

Brand-name coverage depends on your plan, diagnosis, and medication. Some employer plans cover Wegovy or Zepbound for weight loss. Many do not. Hims and Hers offer brand-name access and may help navigate insurance-related steps.

Medicare: The Medicare GLP-1 Bridge program launches in July 2026, covering Wegovy and Zepbound for eligible Part D beneficiaries at a $50 monthly copay. The longer-term BALANCE model launches in Medicaid as early as May 2026 and in Medicare Part D in January 2027. This is a major development — if you are on Medicare, check eligibility details at cms.gov.

Compounded products are generally not covered by insurance.

HSA and FSA: GLP-1 medications prescribed by a licensed clinician are generally eligible. Verify with your plan administrator.

The insurance landscape is shifting, but slowly. More employers are adding GLP-1 coverage — particularly for employees with obesity-related comorbidities. But high deductibles, prior authorization, step therapy, and quantity limits can create friction even when a drug is on your formulary. Have a self-pay backup plan in mind.

Are There GLP-1 Pills for Weight Loss Now?

Yes — and this changes the conversation significantly.

In early 2026, Novo Nordisk launched an oral version of Wegovy, a semaglutide tablet that is FDA-approved specifically for weight loss in adults. This is the first FDA-approved GLP-1 weight-loss pill. Wegovy tablets use their own oral dose-escalation schedule, which differs from the injection titration.

Self-pay pricing under Novo Nordisk’s current program: $149/month for the 1.5 mg and 4 mg doses. After April 15, 2026, the 4 mg dose rises to $199/month. The 9 mg and 25 mg doses are $299/month. These are significantly lower than injectable Wegovy’s list price, though still higher than most compounded programs.

Several compounded providers — including Willow and MEDVi — also offer oral or sublingual tablet options. These compounded oral products are not the same product as FDA-approved Wegovy tablets and are not FDA-approved. The distinction matters: FDA-approved Wegovy tablets went through full regulatory review for safety and effectiveness. Compounded oral options did not.

If avoiding needles is important to you, you now have two clear paths: the FDA-approved oral Wegovy through Hims or Hers (via the Novo Nordisk collaboration — verify current availability), or compounded oral tablets through providers like Willow or MEDVi. Both paths are valid depending on your budget and how much the FDA-approved distinction matters to you.

This development is significant because “I don’t want to inject myself” has been one of the biggest barriers keeping people from starting GLP-1 treatment. That barrier is now largely removed. If you have been on the fence specifically because of needles, 2026 is the year that changed.

Is Compounded Semaglutide Legitimate?

Compounded semaglutide is legal when prepared by a licensed compounding pharmacy under a valid prescription. The FDA regulates compounding pharmacies under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.

However — compounded GLP-1 products are not FDA-approved as finished medications. The FDA has not reviewed them for safety, effectiveness, or manufacturing quality. They are not the same as generic drugs. The FDA’s own guidance states that compounded drugs should only be used when a patient’s clinical needs cannot be met by an FDA-approved product.

The FDA has also warned that some products marketed as “semaglutide” may use salt forms that differ from the approved active ingredient. If you choose a compounded route, ask the provider: which pharmacy prepares your medication, and what quality testing standards do they follow?

What Happens If You Stop, Cancel, or Switch?

If you stop: Weight regain is common after discontinuing GLP-1 therapy. Data from the STEP 1 extension showed participants regained a significant portion of lost weight within a year of stopping. This does not mean the medication “did not work” — it means GLP-1 medications manage appetite and metabolic signals for as long as you take them. Think of it like blood pressure medication: it works while you use it. The best programs help you build sustainable habits alongside the medication so that when you eventually taper, you have a foundation to maintain your progress.

If you cancel: Most providers on this list are month-to-month. Cancellation typically requires 48 to 72 hours notice before your next billing date. Some will not refund medication that has already been ordered or shipped for that cycle. Read the cancellation terms before you sign up — we note key details in each review above.

If you switch: You can. You will need a new health intake with the new provider. Your prescription does not transfer between telehealth platforms — each program uses its own clinician network and pharmacy. Some people switch because of pricing changes, support quality, or wanting to try a different medication format. Switching is normal — just plan for a brief gap between providers.

How Do You Know a GLP-1 Provider Is Legitimate?

How We Ranked and Verified These Providers

We do not list every program that offers an affiliate partnership.

Our evaluation criteria:

1. Pricing transparency — All-in cost clearly stated? Costs change with dose?
2. Medication type clarity — Brand-name vs compounded clearly labeled? No implied equivalence?
3. Clinical oversight — Licensed U.S. clinicians? Meaningful follow-up care?
4. Pharmacy sourcing — Pharmacy partner(s) named or verifiable?
5. Third-party trust signals — Trustpilot rating/volume, regulatory standing
6. Support accessibility — 24/7, business hours, messaging only?
7. Cancellation and refund terms — Month-to-month? What are the actual mechanics?

We check pricing, pharmacy status, and review scores monthly. Last full verification: April 10, 2026.

Affiliate disclosure (in full): We earn commissions when you sign up through some links on this page. This does not affect our scoring, rankings, or analysis. We have declined to feature providers that offered partnerships but did not meet our standards.

Frequently Asked Questions

Ready to Choose? Here Is Your Next Step

If you have read this far, you probably already know which path fits.

Billing models vary by provider. Verify current payment terms on the provider’s site before checkout.

Every program listed above starts with a health intake — a few minutes of your time. From there, a licensed clinician determines if you are a candidate. You are not committing to anything by checking your eligibility. You are just taking the next step.

Sources

1. FDA — Wegovy (semaglutide injection) Prescribing Information. fda.gov/accessdata
2. FDA — Zepbound (tirzepatide injection) Prescribing Information. fda.gov/accessdata
3. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 2021.
4. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 2022.
5. Tirzepatide versus Semaglutide for Weight Loss (SURMOUNT-5). New England Journal of Medicine, 2025.
6. FDA — FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s. Press release, March 3, 2026. fda.gov
7. FDA — FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. fda.gov
8. FDA — Warning letter to MEDVi LLC, February 20, 2026. fda.gov
9. AAMC — GLP-1 Pills for Weight Loss Are Here. aamc.org
10. CMS — Medicare GLP-1 Bridge program and BALANCE Model. cms.gov
11. Novo Nordisk — Wegovy self-pay pricing. wegovy.com
12. Trustpilot — MEDVi reviews. trustpilot.com/review/medvi.org
13. Eden — Program details and Trustpilot reviews. tryeden.com; trustpilot.com
14. Novo Nordisk — Hims & Hers collaboration announcement, March 2026. novonordisk.com
15. FDA — Wegovy tablets prescribing information. fda.gov/accessdata
16. NovoCare — Wegovy coverage and prior authorization. novocare.com
17. FDA — Wegovy injection labeling (includes adolescent use). fda.gov/accessdata

This content is for informational and educational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that require evaluation by a licensed healthcare provider. Compounded GLP-1 products are not FDA-approved as finished medications and are not the same as generic drugs. Individual results vary. Always consult a qualified healthcare provider before starting any medication or weight-loss program.